These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11010667)

  • 1. It's only skin deep: FDA regulation of skin care cosmetics claims.
    Liang BA; Hartman KM
    Cornell J Law Public Policy; 1999; 8(2):249-80. PubMed ID: 11010667
    [No Abstract]   [Full Text] [Related]  

  • 2. Is it time to revise CFR title 21-Food Drugs & Cosmetics Act for skin care products?
    Epstein HA
    Skinmed; 2013; 11(5):297-9. PubMed ID: 24340471
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE; Lustigman AB
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of cosmetics that are also drugs.
    Greff JA
    Food Drug Law J; 1996; 51(2):243-72. PubMed ID: 11820201
    [No Abstract]   [Full Text] [Related]  

  • 5. Legal overview of likely FDA regulation of Internet promotion.
    Scheineson MJ
    Food Drug Law J; 1996; 51(4):697-716. PubMed ID: 11797736
    [No Abstract]   [Full Text] [Related]  

  • 6. A global view of the First Amendment constraints of FDA.
    Carver KH
    Food Drug Law J; 2008; 63(1):151-215. PubMed ID: 18561459
    [No Abstract]   [Full Text] [Related]  

  • 7. Dietary supplement labeling and advertising claims: are clinical studies on the full product required?
    Villafranco JE; Bond K
    Food Drug Law J; 2009; 64(1):43-67. PubMed ID: 19998572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical device labeling and advertising: an overview.
    Basile EM; Armentrout E; Reeves KN
    Food Drug Law J; 1999; 54(4):519-33. PubMed ID: 11824451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kiss and make-up: a need for consolidation of FDA and cosmetic industry regulation programs.
    Mason DE
    Health Matrix Clevel; 2008; 18(1):181-207. PubMed ID: 19161130
    [No Abstract]   [Full Text] [Related]  

  • 10. The FDA Export Reform and Enhancement Act of 1996: the FDA's new extraterritorial authority over labeling and promotional practices.
    Helmanis AM
    Food Drug Law J; 1996; 51(4):631-5. PubMed ID: 11797732
    [No Abstract]   [Full Text] [Related]  

  • 11. Constitutional protection of commercial speech under the Central Hudson test as applied to health claims.
    Schramm MJ
    Food Drug Law J; 1996; 51(2):323-9. PubMed ID: 11822325
    [No Abstract]   [Full Text] [Related]  

  • 12. The Food and Drug Administration's evolving regulation of press releases: limits and challenges.
    Vodra WW; Cortez NG; Korn DE
    Food Drug Law J; 2006; 61(4):623-51. PubMed ID: 17180767
    [No Abstract]   [Full Text] [Related]  

  • 13. The FDA and graphic cigarette-pack warnings--thwarted by the courts.
    Bayer R; Johns D; Colgrove J
    N Engl J Med; 2013 Jul; 369(3):206-8. PubMed ID: 23803139
    [No Abstract]   [Full Text] [Related]  

  • 14. Ambiguities of the Dietary Supplement Health and Education Act of 1994.
    Pinco RG; Rubin PD
    Food Drug Law J; 1996; 51(3):383-405. PubMed ID: 11797716
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulating drug promotion on the Internet.
    Bannon L
    Food Drug Law J; 1999; 54(4):599-621. PubMed ID: 11824457
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary: can we talk? About Food and Drug Regulation and the First Amendment.
    Cohen MN
    Food Drug Law J; 2003; 58(4):741-56. PubMed ID: 15027458
    [No Abstract]   [Full Text] [Related]  

  • 17. The First Amendment and the Food and Drug Administration's regulation of labeling and advertising: three proposed reforms.
    Kahan JS; Shapiro JK
    Food Drug Law J; 2003; 58(3):353-64. PubMed ID: 14626983
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA drops legal battle to introduce graphic pictures on cigarette packs.
    Davies E
    BMJ; 2013 Mar; 346():f1913. PubMed ID: 23526043
    [No Abstract]   [Full Text] [Related]  

  • 19. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
    Leghorn J; Brophy E; Rother P
    Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466
    [No Abstract]   [Full Text] [Related]  

  • 20. Disclaimers in dietary supplement print advertising: the bodybuilding category as a model case for change.
    Soller RW; Rice LG; Ambrose PJ
    Food Drug Law J; 2007; 62(2):375-86. PubMed ID: 17632967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.